ArticleHeliyon2024
SRR inspired inversion symmetry-shaped left-handed metamaterial with a high effective medium ratio for ASR and WLAN applications.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-gain CRLH vivaldi antenna for enhanced channel performance at Ku-band communication systems.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study developed a metamaterial-inspired split-ring resonator (SRR) based inversion symmetry-shaped structure for airport surveillance radar and local area wireless network applications. The proposed device exhibited suitability for S- and C-band applications, featuring distinct resonance peaks at 2.8 and 4.9 GHz, respectively. The two-layer double negative metamaterial unit cell comprises a copper-based resonator, patch, and a low-loss substrate material known as Rogers RT5800 with a thickness of 1.575 mm. The 8 × 8 mm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.